NEOG Neogen Corporation
Healthcare$9.14+2.70%ClosedMarket Cap: $1.99B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.92
P/S
2.23
EV/EBITDA
-3.99
DCF Value
$-20.54
FCF Yield
2.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
39.9%
Operating Margin
-3.7%
Net Margin
-69.9%
ROE
-29.0%
ROA
-18.1%
ROIC
-1.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $211.2M | 46.9% | $-3.3M | $-17.0M | $— | — |
| Q2 null | $224.7M | 47.5% | $-5.4M | $-15.9M | $— | — |
| Q1 null | $209.2M | 34.4% | $-16.0M | $36.3M | $— | — |
| Q4 null | $225.5M | 41.2% | $-13.3M | $-612.2M | $— | — |
| FY null | $894.7M | 47.1% | $9.4M | $-1.09B | $— | — |
| Q3 null | $221.0M | 39.4% | $12.0M | $-11.0M | $— | — |
| Q2 null | $231.3M | 38.8% | $17.1M | $-456.3M | $— | — |
| Q1 null | $217.0M | 39.8% | $8.7M | $-12.6M | $— | — |
| Q4 null | $236.8M | 47.9% | $17.6M | $-5.4M | $— | — |
| FY null | $924.2M | 50.1% | $77.4M | $-9.4M | $— | — |
| Q3 2024 | $228.8M | 50.5% | $11.7M | $-2.0M | $-0.01 | — |
| Q2 2024 | $229.6M | 50.9% | $20.9M | $-3.5M | $-0.02 | — |